1. Home
  2. TLYS vs GLTO Comparison

TLYS vs GLTO Comparison

Compare TLYS & GLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tilly's Inc.

TLYS

Tilly's Inc.

HOLD

Current Price

$1.69

Market Cap

51.2M

ML Signal

HOLD

Logo Galecto Inc.

GLTO

Galecto Inc.

HOLD

Current Price

$24.83

Market Cap

54.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLYS
GLTO
Founded
1982
2011
Country
United States
Denmark
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.2M
54.5M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
TLYS
GLTO
Price
$1.69
$24.83
Analyst Decision
Hold
Strong Buy
Analyst Count
2
2
Target Price
$2.25
$41.00
AVG Volume (30 Days)
83.1K
51.8K
Earning Date
12-03-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$545,742,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.18
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$2.01
52 Week High
$4.60
$38.33

Technical Indicators

Market Signals
Indicator
TLYS
GLTO
Relative Strength Index (RSI) 45.68 53.37
Support Level $1.58 $19.42
Resistance Level $1.86 $24.99
Average True Range (ATR) 0.14 2.89
MACD -0.04 -0.18
Stochastic Oscillator 22.66 35.78

Price Performance

Historical Comparison
TLYS
GLTO

About TLYS Tilly's Inc.

Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.

About GLTO Galecto Inc.

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

Share on Social Networks: